Sotrastaurin
| CAS No. | 425637-18-9 |
|---|---|
| MDL No. | MFCD16038049 |
| MF | C25H22N6O2 |
| MW | 438.50 |
| InChI Key | OAVGBZOFDPFGPJ-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Sotrastaurin is a maleimide substituted at position 3 with an indol-3-yl group and at position 4 with a quinazolin-4-yl group, which is further substituted at position 2 with a 4-methylpiperazin-1-yl group. It is a potent and selective protein kinase C inhibitor, investigated as an immunosuppressant in renal transplant patients. It functions as an EC 2.7.11.13 inhibitor, immunosuppressive agent, and anticoronaviral agent. It is classified as an N-alkylpiperazine, N-arylpiperazine, indole, quinazoline, and maleimide.
| CAS No. | 425637-18-9 |
|---|---|
| Product Name | Sotrastaurin |
Biological Targets
PRKD3·PRKCI·PRKCA·PRKCG·PRKCD·
Associated Conditions
diffuse large B-cell lymphoma·ulcerative colitis·lymphoma·psoriasis·panuveitis·
* The information provided here is compiled from public sources and is for reference only.
